<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03131427</url>
  </required_header>
  <id_info>
    <org_study_id>CR-GMLD</org_study_id>
    <nct_id>NCT03131427</nct_id>
  </id_info>
  <brief_title>China Registry for Genetic / Metabolic Liver Diseases</brief_title>
  <official_title>A Nation-wide Hospital-based Registry:China Registry for Genetic / Metabolic Liver Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing YouAn Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital, Logistics University of People's Armed Police Force</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Second University Hospital of Sichuan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jinshan Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver
      diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis,
      laboratory test results, family history and prescriptions were recorded. Patients' whole
      blood and serum were collected for genetic testing and future researches. These patients will
      be followed-up every six to twelve months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This web-based database was launched on June 13, 2015 and consists of tertiary or secondary
      hospitals with special interest and expertise on managing genetic/metabolic liver diseases
      patients across mainland China. The main inclusion criteria for this registration are
      patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary
      hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or other
      genetic/metabolic liver diseases. At the first time of data entry, demographics, medical
      history, biochemistry and hematology results, radiology reports, diagnosis and treatment
      information were recorded. Patients' whole blood and serum were collected for molecular
      genetic testing and future researches. Then the registered patients will receive standard of
      care and be followed-up every 6 to 12 months. On each visit, biochemical, radiological
      reports, as well as clinical progress were recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2015</start_date>
  <completion_date type="Anticipated">April 28, 2027</completion_date>
  <primary_completion_date type="Anticipated">April 28, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>rate of liver-related events of each disease.</measure>
    <time_frame>10 years</time_frame>
    <description>Rates of cirrhosis, decompensation and hepatocellular carcinoma.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Genotype profile in Chinese patients of each disease</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Natural history of Chinese patients with each disease of different genotype</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Causes of death in Chinese patients of each disease</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>10 years</time_frame>
  </other_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Genetic/Metabolic Liver Diseases</condition>
  <arm_group>
    <arm_group_label>Wilson's Disease</arm_group_label>
    <description>Patients who were diagnosed or possibly diagnosed with Wilson's disease. The diagnosis can be made or possibly made on the basis of Wilson's disease scoring system proposed by the Working Party at the 8th International Meeting on Wilson's disease, Leipzig 2001.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hereditary Hemochromatosis</arm_group_label>
    <description>Hereditary hemochromatosis can be clinically diagnosed if: ① transferrin saturation≥45% and/or elevated ferritin; ② iron overload in liver and/or spleen on magnetic resonance imaging (MRI) of liver or on liver histology; ③ exclude causes of secondary iron overload, such as alcoholic or other chronic liver disease, iron-overloading anemia, and parenteral iron overload.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hereditary Hyperbilirubinemias</arm_group_label>
    <description>Hereditary hyperbilirubinemias involve four syndromes: Gilbert, Crigler-Najjar, Dubin-Johnson and Rotor, among which the first two are characterized by unconjugated hyperbilirubinemia and the second two by conjugated hyperbilirubinemia. Diagnosis of hereditary hyperbilirubinemia should exclude other causes of hyperbilirubinemia, such as obstructive bile duct (slerosing cholangitis, calculi, parasites), intrahepatic cholestasis(drugs, hepatitis, immune-mediated, infectious), acute or chronic hepatocellular injury(sepsis, parenteral nutrition, severe blood loss/hypotension, trauma, conjestive heart failure), increased bilirubin production(hemolysis, hematological disease), decreased bilirubin uptake (drugs, portosystemic shunting ), reduced conjugation activity (neonatal, thyroid disease, chronic hepatitis/inflammation, wilson's disease).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inherited Cholestatic Liver Disease</arm_group_label>
    <description>Patients who were diagnosed or possibly diagnosed with Inherited cholestatic liver disease, including progressive familial intrahepatic cholestasis(PFIC) and benign recurrent intrahepatic cholestasis(BRIC).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other genetic/metabolic liver diseases</arm_group_label>
    <description>Patients who were diagnosed or possibly diagnosed with genetic/metabolic liver diseases except for Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias or inherited cholestatic liver disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard of care according to the updated national and/or international guidelines</description>
    <arm_group_label>Wilson's Disease</arm_group_label>
    <arm_group_label>Hereditary Hemochromatosis</arm_group_label>
    <arm_group_label>Hereditary Hyperbilirubinemias</arm_group_label>
    <arm_group_label>Inherited Cholestatic Liver Disease</arm_group_label>
    <arm_group_label>Other genetic/metabolic liver diseases</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The registry is a multicenter and observational study enrolling patients with
        genetic/metabolic liver disease across mailand China.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary
        hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or
        other genetic/metabolic liver diseases.

        Exclusion Criteria:

        Patients who are unable or unwilling to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jidong Jia, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jidong Jia, MD</last_name>
    <phone>010-63139816</phone>
    <email>jia_jd@ccmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaojuan Ou, MD</last_name>
    <phone>010-63138315</phone>
    <email>ouxj16@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Ditan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Xie, MD</last_name>
      <email>xiewen6218@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanwen Qin, MD</last_name>
      <email>qinyanwen@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanling Yang, MD</last_name>
      <email>organic.acid@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing YouAn Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100069</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujun Zheng, MD</last_name>
      <email>zhengsu.jun003@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongpeng Chen, MD</last_name>
      <email>cyp@smu.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hebei Medical University Third Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050051</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuemin Nan, MD</last_name>
      <email>nanyuemin@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Provincial Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Shang, MD</last_name>
      <email>shangjia666@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Jiang, MD</last_name>
      <email>jiang.wei@zs-hospital.sh.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jinshan Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201508</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianshe Wang, MD</last_name>
      <email>jianshewang@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Women's and Children's Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaomin Wan, MD</last_name>
      <email>wcm0220@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital, Logistics University of People's Armed Police Force</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300163</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hai Li, MD</last_name>
      <email>15202265600@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <zip>830099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaozhong Wang, MD</last_name>
      <email>wxz125@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Xu A, Lv T, Zhang B, Zhang W, Ou X, Huang J. Development and evaluation of an unlabeled probe high-resolution melting assay for detection of ATP7B mutations in Wilson's disease. J Clin Lab Anal. 2017 Jul;31(4). doi: 10.1002/jcla.22064. Epub 2016 Sep 17.</citation>
    <PMID>27638368</PMID>
  </reference>
  <reference>
    <citation>Lv T, Li X, Zhang W, Zhao X, Ou X, Huang J. Recent advance in the molecular genetics of Wilson disease and hereditary hemochromatosis. Eur J Med Genet. 2016 Oct;59(10):532-9. doi: 10.1016/j.ejmg.2016.08.011. Epub 2016 Aug 31. Review.</citation>
    <PMID>27592149</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Jidong Jia</investigator_full_name>
    <investigator_title>Liver Research Center</investigator_title>
  </responsible_party>
  <keyword>Wilson's Disease</keyword>
  <keyword>Hereditary Hemochromatosis</keyword>
  <keyword>Hereditary Hyperbilirubinemias</keyword>
  <keyword>Inherited Cholestatic Liver Disease</keyword>
  <keyword>Genetic Testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

